Douglas & London

What Douglas & London does

Douglas & London is a New York City-based plaintiff-side litigation firm founded in 2002, specializing in personal injury, mass tort, pharmaceutical products liability, medical device, environmental toxic exposure, and medical malpractice cases. The firm operates a contingency fee model in which clients pay no upfront costs and the firm is paid only upon successful resolution; intake is supported by 24/7 free consultations, paid TV/radio advertising, organic social (Facebook, LinkedIn), a blog, and a video library. It serves individual injury victims across all 50 states, Washington D.C., and Puerto Rico, with offices in New York (One State Street, 35th Floor) and New Orleans (935 Gravier Street, Suite 2120), and a co-counsel network of 35+ law firms.

The practice spans 14 discrete service lines including defective drugs (Yasmin/Yaz, Pradaxa, Xarelto, Elmiron, Ozempic, Belviq, Zostavax), defective medical devices (hernia mesh, hip and knee replacements, Philips CPAP, Ethicon surgical staplers), environmental toxic exposure (PFAS/PFOA, C8/DuPont, Camp Lejeune, Roundup, 1,4-Dioxane, ethylene oxide, lead poisoning, Legionnaires' disease, mesothelioma, paraquat), medical malpractice, product liability (3M earplugs, NEC baby formula, hair relaxers, Juul, breast implants), consumer fraud, construction accidents, birth injuries, human trafficking, and Child Victims Act representation. The team comprises 14 named attorneys including five equity partners (Gary J. Douglas, Michael A. London, Stephanie O'Connor, Randolph D. Janis, Virginia E. Anello) plus a managing attorney, senior associates, and associates. Technology footprint is conventional: a content website, blog, video library, and social channels, with no proprietary software platform.

Douglas & London has secured court-appointed leadership in major national MDLs (AFFF/PFAS, PPI MDL 2789, Elmiron MDL 2973, Depo-Provera MDL 3140) and has helped recover over $1 billion for clients since 2002, with cumulative career settlements exceeding $20 billion across founding partner Michael London's tenure since 2005. Landmark outcomes include the $12.5 billion 3M PFAS settlement (largest drinking water settlement in U.S. history), $2 billion+ Yaz/Yasmin settlement, $690 million Zyprexa settlement, $670.6 million C8/DuPont settlement, $650 million Pradaxa settlement, and the first plaintiff verdict in Xarelto litigation at $27.8 million. The firm is privately held as Douglas & London P.C., with ownership concentrated among the founding and senior equity partners and no disclosed outside investment.

Name

Douglas & London

Legal name

Douglas & London

Website

https://douglasandlondon.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Douglas & London is a New York City-based plaintiff law firm specializing in mass tort, personal injury, pharmaceutical, medical device, and environmental toxic exposure cases. Operating on contingency fees, it represents individual injury victims across all 50 states through direct intake and a 35+ firm co-counsel network.

Ownership category

akta.pro rank

Product category

Personal Injury Legal Services

NAICS

Offices of Lawyers (541110)

SIC

Services-Legal Services (8111)

akta.pro primary industry

Personal Injury & Insurance Defense (BPAHAAAM)

Keywords

• Personal injury litigation
• Mass tort lawsuits
• Pharmaceutical product liability
• Medical device litigation
• Environmental toxic exposure

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Contingency Fee Legal Services: Douglas & London operates on a contingency fee basis where clients pay no upfront costs. The firm receives payment only upon successful resolution of cases, taking an agreed-upon percentage of settlements and verdicts. This model aligns firm interests with client outcomes and provides access to justice for those who cannot afford legal fees.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Douglas & London is a New York City-based personal injury and mass tort law firm that represents individuals harmed by negligence, defective pharmaceutical drugs, defective medical devices, environmental toxic exposure, and corporate misconduct. The firm operates on a contingency fee basis with no upfront costs to clients and recovers compensation through settlements and verdicts in complex litigation, including multidistrict litigations (MDLs). Its practice spans personal injury, mass tort, medical malpractice, product liability, consumer fraud, human trafficking, and Child Victims Act representation.

Product overview

Douglas & London is a New York City-based personal injury law firm offering comprehensive legal services through a unified practice focused on representing individuals injured by negligence, defective products, and corporate misconduct. The firm's core offerings span personal injury litigation (car accidents, slip and fall, wrongful death), mass tort and pharmaceutical products liability (defective drugs and medical devices), environmental toxic exposure cases, medical malpractice, product liability, consumer fraud, and specialized areas including human trafficking and Child Victims Act representation. The firm operates on a contingency fee basis, providing free consultations with no fee unless they win the case.

Differentiator

Problem solved

Functional benefit

Products and services

• Personal Injury Legal Services Comprehensive legal representation for individuals injured due to negligence, misconduct, or defective products, including car accidents, slip and fall, wrongful death, and catastrophic injuries.
• Mass Tort Litigation
• Pharmaceutical Products Liability Legal representation for individuals injured by defective prescription medications including Actos, Yasmin/Yaz, Pradaxa, Xarelto, Elmiron, and other harmful drugs.
• Medical Device Products Liability Litigation involving defective medical devices including hernia mesh, hip replacements, knee replacements, Philips CPAP machines, and surgical staplers.
• Environmental Toxic Exposure Legal action against corporate polluters for environmental contamination including PFAS/PFOA water contamination, C8/DuPont litigation, Camp Lejeune, lead poisoning, and other toxic exposures.
• Medical Malpractice Representation for victims of medical negligence including surgical errors, failure to diagnose cancer, birth injuries, cerebral palsy, and Erb's palsy cases.
• Product Liability Cases involving dangerous or defective consumer products including 3M earplugs, NEC baby formula, hair relaxers, Juul/Vaping, sunscreen, and breast implant recalls.
• Consumer Fraud Class action and individual lawsuits against corporations for false advertising, deceptive marketing, and consumer protection violations.
• Human Trafficking/Human Sex Trafficking Legal advocacy for survivors of human trafficking, holding hotels and establishments accountable for enabling sex trafficking on their premises.
• Child Victims Act Representation Legal representation for survivors of child sexual abuse under the New York Child Victims Act, pursuing civil claims against perpetrators and institutions.
• Construction Accident Legal representation for construction workers injured in workplace accidents, scaffold collapses, and site hazards.
• Birth Injury Legal representation for families of infants who suffered injuries at birth including cerebral palsy, Erb's palsy, and kidney damage due to medical negligence.
• Wrongful Death Pursuit of justice and compensation for families who lost loved ones due to negligence, medical malpractice, or defective products.

Quantifiable outcome

• Over $20 billion in verdicts and settlements recovered for clients
• +7 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Katrina McGowan (Director)coreStrategic or Co-development Partner · 27 February 2025Award-winning director Katrina McGowan created the documentary 'How to Poison a Planet' featuring Douglas & London's legal team and actor/activist Mark Ruffalo. The documentary chronicles the firm's efforts to hold 3M and DuPont accountable for PFAS contamination, with settlements totaling nearly $14 billion.
• Mark RuffalocoreStrategic or Co-development Partner · 27 February 2025Actor and activist Mark Ruffalo co-produced and appears in 'How to Poison a Planet' documentary alongside the Douglas & London legal team, helping tell the story of PFAS contamination litigation and the firm's efforts to secure justice for affected communities.
• Co-Counsel Law Firms NetworkcoreChannel Partner/ Reseller/ DistributorDouglas & London works closely with law firms across the country including firms based in Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, West Virginia, Wisconsin, Wyoming and Washington DC. These firms refer cases or serve as co-counsel in nationwide litigation.
• AFFF MDL Plaintiffs' Executive CommitteecoreStrategic or Co-development PartnerDouglas & London collaborated with other members of the AFFF Multi-District Litigation Plaintiffs' Executive Committee to negotiate historic settlements including $12.5 billion from 3M and $1.185 billion from DuPont for PFAS contamination of drinking water supplies.
• NOAH/NY Haitian American AllianceminorOthersCommunity partnership supporting the Haitian American community in New York through charitable initiatives and community outreach.
• Local Development Corporation of East New YorkminorOthersCommunity partnership supporting economic development and community programs in East New York.
• Public Justice FoundationminorOthersNonprofit public interest law firm partnership supporting consumer protection and access to justice initiatives.
• National Multiple Sclerosis (MS) SocietyminorOthersCharitable partnership supporting MS research and patient care programs.
• Susan G. Komen Race for the CureminorOthersBreast cancer research and care initiative partnership.
• Brooklyn Kindergarten SocietyminorOthersEarly childhood education charitable partnership.
• Feel Good FoundationminorOthersCharitable foundation partnership for community support programs.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Levin Papantonio Rafferty: Florida-based plaintiff mass tort firm with active pharmaceutical, medical device, and environmental docket. Direct competitor in MDL leadership roles and contingency fee mass tort work.
• Robins Kaplan: National plaintiff firm with strong mass tort and class action practice, including MDL leadership in pharmaceutical and antitrust cases. Comparable mid-size plaintiff litigation competitor.
• Weitz & Luxenberg: New York-based plaintiff mass tort and personal injury firm with comparable leadership in national MDLs (including asbestos, pharmaceutical, and environmental cases). Direct competitor for court-appointed lead counsel roles and mass tort case origination.
• Lieff Cabraser Heimann & Bernstein: National plaintiff firm with strong mass tort and class action practice, frequently appointed lead counsel in MDLs. Closely comparable in business model (contingency fee) and docket focus on pharmaceutical and consumer product litigation.
• Simmons Hanly Conroy: Illinois-based plaintiff mass tort firm with substantial MDL leadership in asbestos, pharmaceutical, and environmental cases. Comparable scale and contingency fee model with national reach.
• Baron & Budd: Texas-based plaintiff mass tort and environmental litigation firm with deep MDL involvement in water contamination, pharmaceutical, and asbestos cases. Direct competitor for environmental toxic tort work including PFAS.
• Napoli Shkolnik: National plaintiff firm focused on mass tort, pharmaceutical, and environmental litigation with active MDL leadership roles. Comparable mid-size plaintiff firm competing for similar dockets.
• Seeger Weiss: National plaintiff mass tort firm with strong pharmaceutical, medical device, and consumer product liability practice. Frequently serves in MDL leadership positions comparable to Douglas & London's roles.
• Cohen Milstein Sellers & Toll: Plaintiff-focused litigation firm with active mass tort and class action practice in pharmaceutical, consumer protection, and environmental cases. Comparable in MDL leadership and contingency fee model.

Broad incumbents

• Morgan & Morgan: Largest U.S. plaintiff personal injury firm with national advertising scale and broader practice footprint (PI, mass tort, class action, employment). Competes for mass tort claimants and co-counsel relationships, though much larger and more diversified.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/DouglasandLondon
• LinkedInlinkedin.com/company/douglas-&-london-p-c-
• Xx.com/douglaslondonny

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Douglas & London